Related Articles
Evaluation of VEGF and PEDF in prostate cancer: A preliminary study in serum and biopsies
The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
Novel application of three-dimensional shear wave elastography in the detection of clinically significant prostate cancer
Soluble interleukin-6 receptor to interleukin-6 (sIL‑6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy